Wikidata

(Q66077911)

English

Efficacy and Safety of Sofosbuvir/Velpatasvir ± Ribavirin for 12 Weeks in Adults With Chronic HCV Infection and Decompensated Cirrhosis

clinical trial

In more languages

Statements

title
A Multicenter, Randomized, Phase 3, Open-Label Study to Investigate the Efficacy and Safety of Sofosbuvir/Velpatasvir ± Ribavirin for 12 Weeks in Subjects With Chronic HCV Infection and Decompensated Cirrhosis (English)
0 references
medical condition
hepatitis
0 references
hepatitis C
0 references
liver cirrhosis
0 references
country
Japan
0 references
start time
26 December 2016
0 references
end time
13 February 2018
0 references
number of participants
102
0 references
research intervention
sofosbuvir
0 references
velpatasvir
0 references
minimum age
20 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q66077911&oldid=1858792970"